Scabies: Important Clinical Consequences Explained by New Molecular Studies

Pharmacology, Toxicology and Pharmaceutical Science

• Scabies 100%
• Mite 63%
• Diseases 27%
• Rheumatic Fever 18%
• Prevalence 18%
• Streptococcus pyogenes 18%
• Pig 18%
• Sarcoptes Scabiei 9%
• Pruritus 9%
• Infestation 9%
• Morbidity 9%
• Rheumatic Heart Disease 9%
• Protein 9%
• Proteinase 9%
• Infection 9%
• Survival 9%
• Skin Defect 9%
• Infectious Agent 9%
• Cysteine Proteinase 9%
• Staphylococcus Aureus 9%
• Heart Disease 9%
• Host 9%
• Complement Inhibitor 9%
• Immunocompromised Patient 9%
• Bacterial Skin Disease 9%
• Streptococcal Pharyngitis 9%

Medicine and Dentistry

• Scabies 100%
• Diseases 27%
• Therapeutic Procedure 18%
• Rheumatic Fever 18%
• Family 18%
• Exercise 18%
• Streptococcus pyogenes 18%
• Comprehension 9%
• Pruritus 9%
• Morbidity 9%
• Infestation 9%
• Rheumatic Heart Disease 9%
• Cysteine Proteinase 9%
• Proteinase 9%
• Position 9%
• Survival 9%
• Pathogen 9%
• Infection 9%
• Protein 9%
• Biomedical Research 9%
• Heart Disease 9%
• Skin Defect 9%
• Staphylococcus Aureus 9%
• Streptococcal Pharyngitis 9%
• Immunocompromised Patient 9%
• Sequela 9%
• Digestion 9%